Launched in 2014, Swixx BioPharma is today one fastest-growing, largest, independent, intercontinental commercial platforms for the biopharmaceutical industry. The company expands to Latin America through a strategic acquisition and combination with Biopas. This acquisition follows on the entry of Swixx BioPharma into the Middle East region in September 2023.
